
There have been postmarketing reports including angioedema, breast enlargement, diarrhea, dizziness, gynecomastia, headache, nausea, hypersensitivity (skin redness, blisters, hives, rash, dyspnea and wheezing). Following abrupt discontinuation: anxiety, hyperhidrosis, insomnia, nausea, headache and diarrhea.
View ADR Reporting Link